                         SEQUENCE LISTING

<110>  Development Center for Biotechnology
       DCB-USA LLC
 
<120>  ANTI-HUMAN TIM-3 ANTIBODIES AND METHODS OF USE THEREOF

<130>  DCB008-689PCT

<150>  62/440,290
<151>  2016-12-29

<160>  10    

<170>  PatentIn version 3.5

<210>  1
<211>  119
<212>  PRT
<213>  Mus musculus

<400>  1

Glu Val Gln Leu Gln Gln Ser Gly Pro Glu Leu Val Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Met Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Asp Tyr 
            20                  25                  30          


Tyr Met Asn Trp Val Lys Gln Ser His Gly Lys Ser Leu Glu Trp Ile 
        35                  40                  45              


Gly Arg Val Asn Pro Ser Asn Gly Gly Thr Asn Asn Asn Gln Asn Phe 
    50                  55                  60                  


Lys Gly Lys Ala Thr Leu Thr Val Asp Lys Ser Leu Asn Thr Ala Tyr 
65                  70                  75                  80  


Met Gln Leu Asn Ser Leu Thr Ser Glu Asp Ser Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Arg Asp Ser Ser Gly Tyr Trp Phe Ala Tyr Trp Gly Gln Gly 
            100                 105                 110         


Thr Leu Val Thr Val Ser Ala 
        115                 


<210>  2
<211>  108
<212>  PRT
<213>  Mus musculus

<400>  2

Asp Ile Val Met Thr Gln Ser His Lys Phe Met Ser Thr Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Ser Ile Thr Cys Lys Ala Ser Gln Asp Val Ser Thr Ala 
            20                  25                  30          


Val Val Trp Tyr Gln Gln Lys Pro Gly Gln Ser Pro Lys Ile Leu Ile 
        35                  40                  45              


Phe Ser Pro Ser Tyr Arg Tyr Thr Gly Val Pro Asp Arg Phe Thr Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Thr Phe Thr Ile Ser Ser Val Gln Ala 
65                  70                  75                  80  


Glu Asp Leu Ala Val Tyr Tyr Cys Gln Gln His Tyr Asn Ile Pro Trp 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Lys Leu Glu Ile Arg Arg 
            100                 105             


<210>  3
<211>  10
<212>  PRT
<213>  Mus musculus

<400>  3

Gly Tyr Thr Phe Thr Asp Tyr Tyr Met Asn 
1               5                   10  


<210>  4
<211>  17
<212>  PRT
<213>  Mus musculus

<400>  4

Arg Val Asn Pro Ser Asn Gly Gly Thr Asn Asn Asn Gln Asn Phe Lys 
1               5                   10                  15      


Gly 
    


<210>  5
<211>  10
<212>  PRT
<213>  Mus musculus

<400>  5

Arg Asp Ser Ser Gly Tyr Trp Phe Ala Tyr 
1               5                   10  


<210>  6
<211>  11
<212>  PRT
<213>  Mus musculus

<400>  6

Lys Ala Ser Gln Asp Val Ser Thr Ala Val Val 
1               5                   10      


<210>  7
<211>  7
<212>  PRT
<213>  Mus musculus

<400>  7

Ser Pro Ser Tyr Arg Tyr Thr 
1               5           


<210>  8
<211>  9
<212>  PRT
<213>  Mus musculus

<400>  8

Gln Gln His Tyr Asn Ile Pro Trp Thr 
1               5                   


<210>  9
<211>  7
<212>  PRT
<213>  Homo sapiens

<400>  9

Arg Lys Gly Asp Val Ser Leu 
1               5           


<210>  10
<211>  7
<212>  PRT
<213>  Homo sapiens

<400>  10

Glu Lys Phe Asn Leu Lys Leu 
1               5           


